[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate

C103H135N7O49S2 — CID 159807073

IUPAC[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate
SMILESCC[C@@]1(OC(=O)CNC(=O)[C@@H](CSCC2O[C@@H]3O[C@@H]4C(CO)O[C@@H](OC5C(CO)O[C@@H](O[C@@H]6C(CSC[C@@H](NC)C(=O)NCC(=O)O[C@]7(CC)C(=O)OCC8C(=O)N9Cc%10cc%11ccccc%11nc%10C9=CC87)O[C@@H](O[C@@H]7C(CO)O[C@H](O[C@@H]8C(CO)OC(O[C@@H]9C(CO)O[C@H](O[C@H]2[C@H](O)C3O)C(O)[C@H]9O)[C@@H](O)[C@H]8O)C(O)[C@H]7O)C(O)[C@H]6O)C(O)[C@H]5O)C(O)[C@H]4O)CC(=O)CCOCCOCCC(C)=O)C(=O)OCC2C(=O)N3Cc4cc5ccccc5nc4C3=CC21
InChIInChI=1S/C103H135N7O49S2/c1-5-102(50-24-55-66-44(21-42-11-7-9-13-52(42)107-66)28-109(55)91(136)48(50)35-142-100(102)138)158-64(118)26-105-89(134)46(23-47(117)16-18-141-20-19-140-17-15-41(3)116)37-160-39-62-87-73(125)80(132)98(149-62)154-85-60(33-114)145-95(76(128)69(85)121)153-84-59(32-113)148-97(79(131)72(84)124)157-88-63(40-161-38-54(104-4)90(135)106-27-65(119)159-103(6-2)51-25-56-67-45(22-43-12-8-10-14-53(43)108-67)29-110(56)92(137)49(51)36-143-101(103)139)150-99(81(133)74(88)126)155-86-61(34-115)146-94(77(129)70(86)122)151-82-57(30-111)144-93(75(127)68(82)120)152-83-58(31-112)147-96(156-87)78(130)71(83)123/h7-14,21-22,24-25,46,48-51,54,57-63,68-88,93-99,104,111-115,120-133H,5-6,15-20,23,26-40H2,1-4H3,(H,105,134)(H,106,135)/t46-,48?,49?,50?,51?,54-,57?,58?,59?,60?,61?,62?,63?,68-,69-,70-,71-,72-,73-,74-,75+,76?,77?,78?,79?,80?,81?,82-,83-,84?,85-,86-,87-,88-,93?,94-,95+,96-,97+,98-,99+,102+,103+/m1/s1
InChIKeyNKNOSHWAGCFCBA-RXBJYHHVSA-N
MW2319.35 g/mol
LogP-10.10
Rot. Bonds35

About [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate

[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate (PubChem CID 159807073) has the molecular formula C103H135N7O49S2 and a molecular weight of 2319.35 g/mol. Its IUPAC name is [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate.

Molecular Properties

Compound Name[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate
PubChem CID159807073
Molecular FormulaC103H135N7O49S2
Molecular Weight2319.35 g/mol
Exact Mass2317.77
IUPAC Name[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate
SMILESCC[C@@]1(OC(=O)CNC(=O)[C@@H](CSCC2O[C@@H]3O[C@@H]4C(CO)O[C@@H](OC5C(CO)O[C@@H](O[C@@H]6C(CSC[C@@H](NC)C(=O)NCC(=O)O[C@]7(CC)C(=O)OCC8C(=O)N9Cc%10cc%11ccccc%11nc%10C9=CC87)O[C@@H](O[C@@H]7C(CO)O[C@H](O[C@@H]8C(CO)OC(O[C@@H]9C(CO)O[C@H](O[C@H]2[C@H](O)C3O)C(O)[C@H]9O)[C@@H](O)[C@H]8O)C(O)[C@H]7O)C(O)[C@H]6O)C(O)[C@H]5O)C(O)[C@H]4O)CC(=O)CCOCCOCCC(C)=O)C(=O)OCC2C(=O)N3Cc4cc5ccccc5nc4C3=CC21
InChIInChI=1S/C103H135N7O49S2/c1-5-102(50-24-55-66-44(21-42-11-7-9-13-52(42)107-66)28-109(55)91(136)48(50)35-142-100(102)138)158-64(118)26-105-89(134)46(23-47(117)16-18-141-20-19-140-17-15-41(3)116)37-160-39-62-87-73(125)80(132)98(149-62)154-85-60(33-114)145-95(76(128)69(85)121)153-84-59(32-113)148-97(79(131)72(84)124)157-88-63(40-161-38-54(104-4)90(135)106-27-65(119)159-103(6-2)51-25-56-67-45(22-43-12-8-10-14-53(43)108-67)29-110(56)92(137)49(51)36-143-101(103)139)150-99(81(133)74(88)126)155-86-61(34-115)146-94(77(129)70(86)122)151-82-57(30-111)144-93(75(127)68(82)120)152-83-58(31-112)147-96(156-87)78(130)71(83)123/h7-14,21-22,24-25,46,48-51,54,57-63,68-88,93-99,104,111-115,120-133H,5-6,15-20,23,26-40H2,1-4H3,(H,105,134)(H,106,135)/t46-,48?,49?,50?,51?,54-,57?,58?,59?,60?,61?,62?,63?,68-,69-,70-,71-,72-,73-,74-,75+,76?,77?,78?,79?,80?,81?,82-,83-,84?,85-,86-,87-,88-,93?,94-,95+,96-,97+,98-,99+,102+,103+/m1/s1
InChIKeyNKNOSHWAGCFCBA-RXBJYHHVSA-N
XLogP-10.10
TPSA808.02 Ų
H-Bond Donors22
H-Bond Acceptors54
Rotatable Bonds35
Heavy Atoms161
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002319.35
LogP ≤ 5-10.10
H-Bond Donors ≤ 522
H-Bond Acceptors ≤ 1054

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate?
The IUPAC name of [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate (CID 159807073) is [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate.
What is the SMILES notation for [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate?
The canonical SMILES for [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate is CC[C@@]1(OC(=O)CNC(=O)[C@@H](CSCC2O[C@@H]3O[C@@H]4C(CO)O[C@@H](OC5C(CO)O[C@@H](O[C@@H]6C(CSC[C@@H](NC)C(=O)NCC(=O)O[C@]7(CC)C(=O)OCC8C(=O)N9Cc%10cc%11ccccc%11nc%10C9=CC87)O[C@@H](O[C@@H]7C(CO)O[C@H](O[C@@H]8C(CO)OC(O[C@@H]9C(CO)O[C@H](O[C@H]2[C@H](O)C3O)C(O)[C@H]9O)[C@@H](O)[C@H]8O)C(O)[C@H]7O)C(O)[C@H]6O)C(O)[C@H]5O)C(O)[C@H]4O)CC(=O)CCOCCOCCC(C)=O)C(=O)OCC2C(=O)N3Cc4cc5ccccc5nc4C3=CC21.
What is the InChIKey of [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate?
The InChIKey is NKNOSHWAGCFCBA-RXBJYHHVSA-N. The full InChI is InChI=1S/C103H135N7O49S2/c1-5-102(50-24-55-66-44(21-42-11-7-9-13-52(42)107-66)28-109(55)91(136)48(50)35-142-100(102)138)158-64(118)26-105-89(134)46(23-47(117)16-18-141-20-19-140-17-15-41(3)116)37-160-39-62-87-73(125)80(132)98(149-62)154-85-60(33-114)145-95(76(128)69(85)121)153-84-59(32-113)148-97(79(131)72(84)124)157-88-63(40-161-38-54(104-4)90(135)106-27-65(119)159-103(6-2)51-25-56-67-45(22-43-12-8-10-14-53(43)108-67)29-110(56)92(137)49(51)36-143-101(103)139)150-99(81(133)74(88)126)155-86-61(34-115)146-94(77(129)70(86)122)151-82-57(30-111)144-93(75(127)68(82)120)152-83-58(31-112)147-96(156-87)78(130)71(83)123/h7-14,21-22,24-25,46,48-51,54,57-63,68-88,93-99,104,111-115,120-133H,5-6,15-20,23,26-40H2,1-4H3,(H,105,134)(H,106,135)/t46-,48?,49?,50?,51?,54-,57?,58?,59?,60?,61?,62?,63?,68-,69-,70-,71-,72-,73-,74-,75+,76?,77?,78?,79?,80?,81?,82-,83-,84?,85-,86-,87-,88-,93?,94-,95+,96-,97+,98-,99+,102+,103+/m1/s1.
What are the key properties of [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate?
[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate has a molecular weight of 2319.35 g/mol, XLogP of -10.10, 35 rotatable bonds, 22 hydrogen bond donors, and 54 hydrogen bond acceptors.
Where does this data come from?
All data for [(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl] 2-[[(2S)-2-[[(1S,3S,6S,8R,11S,16S,18R,21S,23R,26S,28S,33S,36R,38R,40R,42R,44R,45S,46R,48R)-25-[[(2S)-3-[[2-[[(19S)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10-hexaen-19-yl]oxy]-2-oxoethyl]amino]-2-(methylamino)-3-oxopropyl]sulfanylmethyl]-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,30,35-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methylsulfanylmethyl]-4-oxo-6-[2-(3-oxobutoxy)ethoxy]hexanoyl]amino]acetate is sourced from PubChem (CID 159807073), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).